NovoCure Ltd Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27 2017 | NVCR | Novocure Ltd | Pomona Capital VII, L.P. | 10% Owner | Sell | S | 17.46 | 30,945 | 540,204 | 2,741,925 | 2.8 M to 2.7 M (-1.12 %) |
| Jun 27 2017 | NVCR | Novocure Ltd | Pomona Capital VII, L.P. | 10% Owner | Sell | S | 17.46 | 68,396 | 1,193,982 | 6,060,403 | 6.1 M to 6.1 M (-1.12 %) |
| Jun 27 2017 | NVCR | Novocure Ltd | Pomona Capital VII, L.P. | 10% Owner | Sell | S | 17.34 | 303,149 | 5,255,906 | 2,772,870 | 3.1 M to 2.8 M (-9.86 %) |
| Jun 27 2017 | NVCR | Novocure Ltd | Pomona Capital VII, L.P. | 10% Owner | Sell | S | 17.34 | 670,042 | 11,616,987 | 6,128,799 | 6.8 M to 6.1 M (-9.86 %) |
| Jun 22 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 16.78 | 66,361 | 1,113,206 | 222,722 | 289.1 K to 222.7 K (-22.96 %) |
| Jun 21 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.06 | 15,000 | 225,885 | 289,083 | 304.1 K to 289.1 K (-4.93 %) |
| Jun 21 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.51 | 124,720 | 1,934,906 | 896,917 | 1 M to 896.9 K (-12.21 %) |
| Jun 19 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.02 | 9,212 | 138,346 | 1,021,637 | 1 M to 1 M (-0.89 %) |
| Jun 19 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.19 | 33,245 | 504,892 | 1,030,849 | 1.1 M to 1 M (-3.12 %) |
| Jun 15 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.01 | 9,044 | 135,769 | 304,083 | 313.1 K to 304.1 K (-2.89 %) |
| Jun 15 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Option Exercise | M | 3.59 | 6,498 | 23,328 | 0 | |
| Jun 15 2017 | NVCR | Novocure Ltd | DOYLE WILLIAM F | Director | Buy | M | 3.59 | 6,498 | 23,328 | 91,197 | 84.7 K to 91.2 K (+7.67 %) |
| Jun 15 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.01 | 5,402 | 81,068 | 1,064,094 | 1.1 M to 1.1 M (-0.51 %) |
| Jun 15 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.23 | 88,700 | 1,351,078 | 1,069,496 | 1.2 M to 1.1 M (-7.66 %) |
| Jun 13 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.09 | 5,100 | 76,934 | 1,158,196 | 1.2 M to 1.2 M (-0.44 %) |
| Jun 13 2017 | NVCR | Novocure Ltd | Danziger Asaf | Chief Executive Off ... | Sell | S | 15.13 | 175,501 | 2,654,979 | 1,163,296 | 1.3 M to 1.2 M (-13.11 %) |
| Jun 13 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.08 | 5,956 | 89,828 | 313,127 | 319.1 K to 313.1 K (-1.87 %) |
| Jun 13 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.02 | 15,000 | 225,225 | 319,083 | 334.1 K to 319.1 K (-4.49 %) |
| Jun 06 2017 | NVCR | Novocure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 13.82 | 3,825 | 52,842 | 0 | 3.8 K to 0 (-100.00 %) |
| Jun 05 2017 | NVCR | Novocure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 13.49 | 4,000 | 53,956 | 3,825 | 7.8 K to 3.8 K (-51.12 %) |
| Jun 05 2017 | NVCR | Novocure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 13.05 | 4,000 | 52,184 | 7,825 | 11.8 K to 7.8 K (-33.83 %) |
| Jun 01 2017 | NVCR | Novocure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 12.47 | 4,000 | 49,892 | 11,825 | 15.8 K to 11.8 K (-25.28 %) |
| Jun 01 2017 | NVCR | Novocure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 12.50 | 4,000 | 50,004 | 15,825 | 19.8 K to 15.8 K (-20.18 %) |